Effects on atrial fibrillation in aged hypertensive rats by Ca(2+)-activated K(+) channel inhibition
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Standard
Effects on atrial fibrillation in aged hypertensive rats by Ca(2+)-activated K(+) channel inhibition. / Diness, Jonas Goldin; Skibsbye, Lasse; Jespersen, Thomas; Bartels, Emil D; Sørensen, Ulrik S; Hansen, Rie S; Grunnet, Morten.
I: Hypertension, Bind 57, Nr. 6, 2011, s. 1129-35.Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Effects on atrial fibrillation in aged hypertensive rats by Ca(2+)-activated K(+) channel inhibition
AU - Diness, Jonas Goldin
AU - Skibsbye, Lasse
AU - Jespersen, Thomas
AU - Bartels, Emil D
AU - Sørensen, Ulrik S
AU - Hansen, Rie S
AU - Grunnet, Morten
PY - 2011
Y1 - 2011
N2 - We have shown previously that inhibition of small conductance Ca(2+)-activated K(+) (SK) channels is antiarrhythmic in models of acutely induced atrial fibrillation (AF). These models, however, do not take into account that AF derives from a wide range of predisposing factors, the most prevalent being hypertension. In this study we assessed the effects of two different SK channel inhibitors, NS8593 and UCL1684, in aging, spontaneously hypertensive rats to examine their antiarrhythmic properties in a setting of hypertension-induced atrial remodeling. Male spontaneously hypertensive rats and the normotensive Wistar-Kyoto rat strain were divided in 2×3 groups of animals aged 3, 8, and 11 months, respectively. The animals were randomly assigned to treatment with NS8593, UCL1684, or vehicle, and open chest in vivo experiments including burst pacing-induced AF were performed. The aging spontaneously hypertensive rats were more vulnerable to AF induction both by S2 stimulation and burst pacing. Vehicle affected neither the atrial effective refractory period nor AF duration. SK channel inhibition with NS8593 and UCL1684 significantly increased the atrial effective refractory period and decreased AF duration in both the normotensive and hypertensive strains with no decline in efficacy as age increased. In conclusion, SK channel inhibition with NS8593 and UCL1684 possesses antiarrhythmic properties in a rat in vivo model of paroxysmal AF with hypertension-induced atrial remodeling. The present results support the notion that SK channels may offer a promising new therapeutic target in the treatment of AF.
AB - We have shown previously that inhibition of small conductance Ca(2+)-activated K(+) (SK) channels is antiarrhythmic in models of acutely induced atrial fibrillation (AF). These models, however, do not take into account that AF derives from a wide range of predisposing factors, the most prevalent being hypertension. In this study we assessed the effects of two different SK channel inhibitors, NS8593 and UCL1684, in aging, spontaneously hypertensive rats to examine their antiarrhythmic properties in a setting of hypertension-induced atrial remodeling. Male spontaneously hypertensive rats and the normotensive Wistar-Kyoto rat strain were divided in 2×3 groups of animals aged 3, 8, and 11 months, respectively. The animals were randomly assigned to treatment with NS8593, UCL1684, or vehicle, and open chest in vivo experiments including burst pacing-induced AF were performed. The aging spontaneously hypertensive rats were more vulnerable to AF induction both by S2 stimulation and burst pacing. Vehicle affected neither the atrial effective refractory period nor AF duration. SK channel inhibition with NS8593 and UCL1684 significantly increased the atrial effective refractory period and decreased AF duration in both the normotensive and hypertensive strains with no decline in efficacy as age increased. In conclusion, SK channel inhibition with NS8593 and UCL1684 possesses antiarrhythmic properties in a rat in vivo model of paroxysmal AF with hypertension-induced atrial remodeling. The present results support the notion that SK channels may offer a promising new therapeutic target in the treatment of AF.
KW - 1-Naphthylamine
KW - Age Factors
KW - Alkanes
KW - Animals
KW - Anti-Arrhythmia Agents
KW - Atrial Fibrillation
KW - Cardiac Pacing, Artificial
KW - Disease Models, Animal
KW - Humans
KW - Hypertension
KW - Injections, Intravenous
KW - Male
KW - Potassium Channel Blockers
KW - Potassium Channels, Calcium-Activated
KW - Quinolinium Compounds
KW - Random Allocation
KW - Rats
KW - Rats, Inbred SHR
KW - Rats, Inbred WKY
KW - Species Specificity
KW - Time Factors
U2 - 10.1161/HYPERTENSIONAHA.111.170613
DO - 10.1161/HYPERTENSIONAHA.111.170613
M3 - Journal article
C2 - 21502564
VL - 57
SP - 1129
EP - 1135
JO - Hypertension
JF - Hypertension
SN - 0194-911X
IS - 6
ER -
ID: 37726347